HROW ファイナンス： Harrow Inc AI分析

ホーム

株式

HROW

HROW 財務

Harrow Inc

$48.38

2.67%

$1.26

本日現在の状況：Feb 13, 14:30:53 GMT-5

概要予測収入配当財務状況

主要データ

前終値

$47.12

始値

$48.17

当日レンジ

$47.7 - $49.2

52週レンジ

$20.85 - $54.85

取引高

150.8K

平均取引高

552.5K

1株当たり利益(TTM)

-0.15

配当利回り

時価総額

$1.7B

HROWとは何ですか？

Harrow, Inc. engages in the development, production, and sale of innovative medications. The company is headquartered in Nashville, Tennessee and currently employs 382 full-time employees. The company went IPO on 2013-02-08. The company offers a portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and retina diseases. The company owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. The company owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. The company owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE, BYQLOVI and others. Its product candidates include MELT-210, MELT-300 and MELT-400. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms.

特徴

リソース

市場

収入

貸借対照表

現金の流れ

年次

四半期

HROW 収入

金額は百万米ドル単位。会計年度は2月から1月まで。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
収入	250	199	130	88	72	48
収益成長率（YoY）	48%	53%	48%	22%	50%	-6%
収益のコスト	63	49	39	25	18	14
売上総利益	186	150	90	63	54	34
販売、一般および管理	144	129	83	58	41	31
研究開発	13	12	6	3	11	2
運営費用	158	141	89	61	52	33
その他の非営業収入（費用）	0	0	0	0	0	--
税引前利益	-5	-17	-23	-14	-17	-3
所得税費	--	0	0	0	0	0
純利益	-4	-17	-24	-14	-18	-3
純利益成長率	-88%	-28.99%	71%	-22%	500%	--
流通済み株式数（希薄化後）	38.87	35.65	32.61	27.46	26.76	25.9
株式変動（前年比）	8%	9%	19%	3%	3%	-2%
EPS（希薄化）	-0.12	-0.49	-0.74	-0.51	-0.69	-0.13
EPS成長率	-87%	-34%	47%	-26%	430.99%	-1,400%
フリーキャッシュフロー	-20	-60	-148	0	3	-1
1株当たりフリーキャッシュフロー	--	--	--	--	--	--
粗利益	74.4%	75.37%	69.23%	71.59%	75%	70.83%
営業利益率	11.2%	4.52%	0%	1.13%	1.38%	0%
利益率	-1.6%	-8.54%	-18.46%	-15.9%	-25%	-6.25%
フリーキャッシュフロー利益率	-8%	-30.15%	-113.84%	0%	4.16%	-2.08%
EBITDA	46	22	11	4	2	2
EBITDAマージン	18.4%	11.05%	8.46%	4.54%	2.77%	4.16%
D&A による EBITDA	18	13	11	3	1	2
営業利益	28	9	0	1	1	0
営業利益率	11.2%	4.52%	0%	1.13%	1.38%	0%
実効税率	--	0%	0%	0%	0%	0%

Harrow Inc (HROW)価格

HROW 株価推移チャート